Articles of Potential Interest
August 2007*
Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM. 2007. Use
of selective serotonin-reuptake inhibitors in pregnancy and
the risk of birth defects. N Engl J Med 356(26): 2684-2692. Abstract
Chi WX, Wang JF, Li XH, Zheng XY, Liao YL. 2007. Bayesian
mapping of neural tube defects prevalence in Heshun County,
Shanxi Province, China during 1998 similar to 2001.
J Zhejiang Univ Sci A 8(6): 921-925. Abstract
Cole JA, Modell JG, Haight BR, Cosmatos IS, Stoler JM, Walker
AM. 2007. Bupropion in pregnancy and the prevalence of
congenital malformations. Pharmacoepidemiol Drug Saf
16(5): 474-484. Abstract
De Wals P, Tairou F, Van Allen MI, Uh S, Lowry RB, Sibbald B,
Evans JA, Van den Hof MC, Zimmer P, Crowley M, Fernandez B, Lee
NS, Niyonsenga T. 2007. Reduction in neural-tube defects
after folic acid fortification in Canada. New Engl J
Med 357(2): 135-142. Abstract
Dunlevy LPE, Chitty LS, Burren KA, Doudney K, Stojilkovic-Mikic
T, Stanier P, Scott R, Copp AJ, Greene NDE. 2007. Abnormal
folate metabolism in foetuses affected by neural tube defects.
Brain 130: 1043-1049. Abstract
Frey GM, Ott MG, Messerer P, Nasterlack M, Zober A, Queisser-Luft
A. 2007. Pregnancy protection program in a large chemical
company: infant outcomes. J Occup Environ Med 49(5):
519-525. Abstract
Kelsall HL, Sim MR, Ikin JF, Forbes AB, McKenzie DP, Glass DC,
Ittak P. 2007. Reproductive health of male Australian
veterans of the 1991 Gulf War. BMC Public Health 7:
79. Abstract
Kloosterman J, Fransen HP, de Stoppelaar J, Verhagen H, Rompelberg
C. 2007. Safe addition of vitamins and minerals to foods:
setting maximum levels for fortification in the Netherlands.
Eur J Nutr 46(4): 220-229. Abstract
Krauss-Etschmann S, Shadid R, Campoy C, Hoster E, Demmelmair
H, Jimenez M, Gil A, Rivero M, Veszpremi B, Decsi T, Koletzko
BV. 2007. Effects of fish-oil and folate supplementation
of pregnant women on maternal and fetal plasma concentrations
of docosahexaenoic acid and eicosapentaenoic acid: a European
randomized multicenter trial. Am J Clin Nutr 85(5):
1392-1400. Abstract
Louik C, Lin AE, Werler MM, Hernandez-Diaz S, Mitchell AA. 2007. First-trimester
use of selective serotonin-reuptake inhibitors and the risk
of birth defects. N Engl J Med 356(26): 2675-2683. Abstract
Mossey PA, Davies JA, Little J. 2007. Prevention of
orofacial clefts: Does pregnancy planning have a role? Cleft
Palate Craniofac J 44(3): 244-250. Abstract
Nava-Ocampo AA, Koren G. 2007. Human teratogens and
evidence-based teratogen risk counseling: the motherisk approach.
Clin Obstet Gynecol 50(1): 123-131. Abstract
Viste J. 2007. Communicating (birth defects) prevention
information to a Hmong population in Wisconsin: a study of
cultural relevance. Subst Use Misuse 42(4): 753-774. Abstract
Vittorini S, Storti S, Parri MS, Cerillo AG, Clerico A. 2007. SERCA2a,
phospholamban, sarcolipin, and ryanodine receptors gene expression
in children with congenital heart defects. Mol Med
13(1-2): 105-111. Abstract
Weingartner J, Maile S, Proff P, Reicheneder C, Bienengraber
V, Fanghanel J, Gedrange T. 2007. Secondary palatal closure
in rats in association with relative maternofetal levels of folic
acid, vitamin B12, and homocysteine. Ann Anat 189(3):
229-233. Abstract
Yang J, Cummings EA, O'Connell C, Jangaard K. 2006. Fetal
and neonatal outcomes of diabetic pregnancies. Obstet
Gynecol 108(3): 644-650. Abstract
Yang QH, Carter HK, Mulinare J, Berry RJ, Friedman JM, Erickson
JD. 2007. Race-ethnicity differences in folic acid intake
in women of childbearing age in the United States after folic
acid fortification: findings from the National Health and Nutrition
Examination Survey, 2001-2002. Am J Clin Nutr 85(5):
1409-1416. Abstract
This list was compiled from searches
of articles published in July 2007. Questions or comments about
this list may be sent to webmaster@nbdpn.org.
